Detalhe da pesquisa
1.
Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes.
Haematologica
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572567
2.
Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysis.
Hemasphere
; 8(6): e87, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38873532
3.
A comparison of peripheral blood stem cell collection outcomes for multiple myeloma; mobilization matters in the era of IMiD induction.
EJHaem
; 4(3): 625-630, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37601867
4.
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic.
Blood Cancer J
; 13(1): 38, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922489
5.
Immune senescence in multiple myeloma-a role for mitochondrial dysfunction?
Leukemia
; 36(10): 2368-2373, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35879358
6.
NK cells CD56bright and CD56dim subset cytokine loss and exhaustion is associated with impaired survival in myeloma.
Blood Adv
; 6(17): 5152-5159, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35834731
7.
Reducing tropical deforestation.
Science
; 365(6455): 756-757, 2019 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31439784